| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ORIGINAL ARTICLES |
From the Departments of Surgery (KJVZ, DMEM, JLBB, SKB, JVF, PIB, HSC), Pathology (LKT), and Urology, Epidemiology and Biostatistics (MWK), Memorial Sloan-Kettering Cancer Center, New York, New York.
Correspondence: Address correspondence and reprint requests to: Kimberly J. Van Zee, MS, MD, FACS, 1275 York Ave., MRI-1026, New York, NY 10021; Fax: 212-7945812; E-mail: vanzeek{at}mskcc.org
Background: The standard of care for breast cancer patients with sentinel lymph node (SLN) metastases includes complete axillary lymph node dissection (ALND). However, many question the need for complete ALND in every patient with detectable SLN metastases, particularly those perceived to have a low risk of non-SLN metastases. Accurate estimates of the likelihood of additional disease in the axilla could assist greatly in decision-making regarding further treatment.
Methods: Pathological features of the primary tumor and SLN metastases of 702 patients who underwent complete ALND were assessed with multivariable logistic regression to predict the presence of additional disease in the non-SLNs of these patients. A nomogram was created using pathological size, tumor type and nuclear grade, lymphovascular invasion, multifocality, and estrogen-receptor status of the primary tumor; method of detection of SLN metastases; number of positive SLNs; and number of negative SLNs. The model was subsequently applied prospectively to 373 patients.
Results: The nomogram for the retrospective population was accurate and discriminating, with an area under the receiver operating characteristic (ROC) curve of 0.76. When applied to the prospective group, the model accurately predicted likelihood of non-SLN disease (ROC, 0.77).
Conclusions: We have developed a user-friendly nomogram that uses information commonly available to the surgeon to easily and accurately calculate the likelihood of having additional, non-SLN metastases for an individual patient.
Key Words: Axillary metastases Breast cancer Nomogram Prediction Sentinel node
This article has been cited by other articles:
![]() |
K. Y. Bilimoria, D. J. Bentrem, N. M. Hansen, K. P. Bethke, A. W. Rademaker, C. Y. Ko, D. P. Winchester, and D. J. Winchester Comparison of Sentinel Lymph Node Biopsy Alone and Completion Axillary Lymph Node Dissection for Node-Positive Breast Cancer J. Clin. Oncol., June 20, 2009; 27(18): 2946 - 2953. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Coutant, C. Olivier, E. Lambaudie, E. Fondrinier, F. Marchal, F. Guillemin, N. Seince, V. Thomas, J. Leveque, E. Barranger, et al. Comparison of Models to Predict Nonsentinel Lymph Node Status in Breast Cancer Patients With Metastatic Sentinel Lymph Nodes: A Prospective Multicenter Study J. Clin. Oncol., June 10, 2009; 27(17): 2800 - 2808. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. E. McCahill, A. Privette, T. James, J. Sheehey-Jones, J. Ratliff, D. Majercik, D. N. Krag, M. Stanley, and S. Harlow Quality Measures for Breast Cancer Surgery: Initial Validation of Feasibility and Assessment of Variation Among Surgeons Arch Surg, May 1, 2009; 144(5): 455 - 462. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Pugliese, J. D. Beatty, R. J. Tickman, K. H. Allison, M. K. Atwood, J. Szymonifka, Z. M. Arthurs, P. P. Huynh, and J. H. Dawson Impact and Outcomes of Routine Microstaging of Sentinel Lymph Nodes in Breast Cancer: Significance of the pN0(i+) and pN1mi Categories Ann. Surg. Oncol., January 1, 2009; 16(1): 113 - 120. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. H. Lyman, K. J. Van Zee, and S. B. Edge Impact and Remaining Challenges in the Use of Sentinel Lymph Node Biopsy in Early-stage Breast Cancer ASCO Educational Book, January 1, 2009; 2009(1): 346 - 353. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Mittendorf, A. A. Sahin, S. L. Tucker, F. Meric-Bernstam, M. Yi, K. M. Nayeemuddin, G. V. Babiera, M. I. Ross, B. W. Feig, H. M. Kuerer, et al. Lymphovascular Invasion and Lobular Histology are Associated with Increased Incidence of Isolated Tumor Cells in Sentinel Lymph Nodes from Early-Stage Breast Cancer Patients Ann. Surg. Oncol., December 1, 2008; 15(12): 3369 - 3383. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. S. Cody III and K. J. Van Zee Predicting Nonsentinel Node Metastases in Sentinel Node-Positive Breast Cancer: What Have We Learned, Can We Do Better, and Do We Need To? Ann. Surg. Oncol., November 1, 2008; 15(11): 2998 - 3002. [Full Text] [PDF] |
||||
![]() |
J. Cho, W. Han, and D.-Y. Noh What Is the Best? Ann. Surg. Oncol., November 1, 2008; 15(11): 3317 - 3317. [Full Text] [PDF] |
||||
![]() |
E. Poirier, L. Sideris, P. Dube, P. Drolet, and S. H. Meterissian Analysis of Clinical Applicability of the Breast Cancer Nomogram for Positive Sentinel Lymph Node: The Canadian Experience Ann. Surg. Oncol., September 1, 2008; 15(9): 2562 - 2567. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Cho, W. Han, J. W. Lee, E. Ko, S. Y. Kang, S.-Y. Jung, E.-K. Kim, W. K. Moon, N. Cho, I.-A. Park, et al. A Scoring System to Predict Nonsentinel Lymph Node Status in Breast Cancer Patients with Metastatic Sentinel Lymph Nodes: A Comparison with Other Scoring Systems Ann. Surg. Oncol., August 1, 2008; 15(8): 2278 - 2286. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. D. Bear Completion Axillary Lymph Node Dissection for Breast Cancer: Immediate Versus Delayed Versus None J. Clin. Oncol., July 20, 2008; 26(21): 3483 - 3484. [Full Text] [PDF] |
||||
![]() |
J. A. Olson Jr, L. M. McCall, P. Beitsch, P. W. Whitworth, D. S. Reintgen, P. W. Blumencranz, A. M. Leitch, S. Saha, K. K. Hunt, and A. E. Giuliano Impact of Immediate Versus Delayed Axillary Node Dissection on Surgical Outcomes in Breast Cancer Patients With Positive Sentinel Nodes: Results From American College of Surgeons Oncology Group Trials Z0010 and Z0011 J. Clin. Oncol., July 20, 2008; 26(21): 3530 - 3535. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Vanderveen, R. Ramsamooj, and R. J. Bold A Prospective, Blinded Trial of Touch Prep Analysis versus Frozen Section for Intraoperative Evaluation of Sentinel Lymph Nodes in Breast Cancer Ann. Surg. Oncol., July 1, 2008; 15(7): 2006 - 2011. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. R. Konig, A. Ziegler, E. Bluhmki, W. Hacke, P. M.W. Bath, R. L. Sacco, H. C. Diener, C. Weimar, and on behalf of the Virtual International Stroke Tria Predicting Long-Term Outcome After Acute Ischemic Stroke: A Simple Index Works in Patients From Controlled Clinical Trials Stroke, June 1, 2008; 39(6): 1821 - 1826. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Samphao, J. M. Eremin, M. El-Sheemy, and O. Eremin Management of the Axilla in Women With Breast Cancer: Current Clinical Practice and a New Selective Targeted Approach Ann. Surg. Oncol., May 1, 2008; 15(5): 1282 - 1296. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. H. M. van Deurzen, C. A. Seldenrijk, R. Koelemij, R. van Hillegersberg, M. G. G. Hobbelink, and P. J. van Diest The Microanatomic Location of Metastatic Breast Cancer in Sentinel Lymph Nodes Predicts Nonsentinel Lymph Node Involvement Ann. Surg. Oncol., May 1, 2008; 15(5): 1309 - 1315. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Wang, C. D. Fuller, J.-S. Kim, D. F. Sittig, C. R. Thomas Jr, and P. M. Ravdin Prediction Model for Estimating the Survival Benefit of Adjuvant Radiotherapy for Gallbladder Cancer J. Clin. Oncol., May 1, 2008; 26(13): 2112 - 2117. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. K. Tan, D. Giri, A. J. Hummer, K. S. Panageas, E. Brogi, L. Norton, C. Hudis, P. I. Borgen, and H. S. Cody III Occult Axillary Node Metastases in Breast Cancer Are Prognostically Significant: Results in 368 Node-Negative Patients With 20-Year Follow-Up J. Clin. Oncol., April 10, 2008; 26(11): 1803 - 1809. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Barranger, O. Morel, and C. Coutant Axilla Scoring Systems Predicting Risk of Non-sentinel-node Metastasis in Breast Cancer Patients with a Positive Sentinel Node Ann. Surg. Oncol., April 1, 2008; 15(4): 1261 - 1262. [Full Text] [PDF] |
||||
![]() |
C. Dauphine In Reply Ann. Surg. Oncol., April 1, 2008; 15(4): 1263 - 1264. [Full Text] [PDF] |
||||
![]() |
A. M. Fink, H. Lass, H. Hartleb, W. Jurecka, H. Salzer, and A. Steiner S-Classification of Sentinel Lymph Node Predicts Axillary Nonsentinel Lymph Node Status in Patients with Breast Cancer Ann. Surg. Oncol., March 1, 2008; 15(3): 848 - 853. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Somasundaram, D. W. Chicken, and M. R. S. Keshtgar Detection of the sentinel lymph node in breast cancer Br. Med. Bull., January 3, 2008; (2008) ldm032v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. G. Van den Eynden, M. K. Vandenberghe, P.-J. H. van Dam, C. G. Colpaert, P. van Dam, L. Y. Dirix, P. B. Vermeulen, and E. A. Van Marck Increased Sentinel Lymph Node Lymphangiogenesis is Associated with Nonsentinel Axillary Lymph Node Involvement in Breast Cancer Patients with a Positive Sentinel Node Clin. Cancer Res., September 15, 2007; 13(18): 5391 - 5397. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. B. Bevilacqua, M. W. Kattan, J. V. Fey, H. S. Cody III, P. I. Borgen, and K. J. Van Zee Doctor, What Are My Chances of Having a Positive Sentinel Node? A Validated Nomogram for Risk Estimation J. Clin. Oncol., August 20, 2007; 25(24): 3670 - 3679. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Van Zee and M. W. Kattan Validating a Predictive Model for Presence of Additional Disease in the Non Sentinel Lymph Nodes of a Woman with Sentinel Node Positive Breast Cancer Ann. Surg. Oncol., August 1, 2007; 14(8): 2177 - 2178. [Full Text] [PDF] |
||||
![]() |
S. Alran, Y. De Rycke, V. Fourchotte, H. Charitansky, F. Laki, M. C. Falcou, M. Benamor, P. Freneaux, R. J. Salmon, for the Institut Curie Breast Cancer Study Group, et al. Validation and Limitations of Use of a Breast Cancer Nomogram Predicting the Likelihood of Non Sentinel Node Involvement After Positive Sentinel Node Biopsy Ann. Surg. Oncol., August 1, 2007; 14(8): 2195 - 2201. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Lambert, G. D. Ayers, and F. Meric-Bernstam Validation of a Breast Cancer Nomogram for Predicting Nonsentinel Lymph Node Metastases after a Positive Sentinel Node Biopsy Ann. Surg. Oncol., August 1, 2007; 14(8): 2422 - 2423. [Full Text] [PDF] |
||||
![]() |
S. Pruthi, K. R. Brandt, A. C. Degnim, M. P. Goetz, E. A. Perez, C. A. Reynolds, P. J. Schomberg, G. K. Dy, and J. N. Ingle A Multidisciplinary Approach to the Management of Breast Cancer, Part 1: Prevention and Diagnosis Mayo Clin. Proc., August 1, 2007; 82(8): 999 - 1012. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Dauphine, J. S. Haukoos, M. P. Vargas, N. M. Isaac, I. Khalkhali, and H. I. Vargas Evaluation of Three Scoring Systems Predicting Non Sentinel Node Metastasis in Breast Cancer Patients with a Positive Sentinel Node Biopsy Ann. Surg. Oncol., March 1, 2007; 14(3): 1014 - 1019. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Pugliese, R. Tickman, N. P. Wang, M. Atwood, and J D. Beatty The Utility of Intraoperative Evaluation of Sentinel Lymph Nodes in Breast Cancer Ann. Surg. Oncol., March 1, 2007; 14(3): 1024 - 1030. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Smidt, L. J. A. Strobbe, H. M. M. Groenewoud, G. J. der Wilt, K. J. Van Zee, and T. Wobbes Can Surgical Oncologists Reliably Predict the Likelihood for Non-SLN Metastases in Breast Cancer Patients? Ann. Surg. Oncol., February 1, 2007; 14(2): 615 - 620. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. B. Chagpar, C. R. Scoggins, R. C. G. Martin 2nd, E. F. Cook, T. McCurry, N. Mizuguchi, K. J. Paris, D. J. Carlson, A. L. Laidley, S. E. El-Eid, et al. Predicting Patients at Low Probability of Requiring Postmastectomy Radiation Therapy Ann. Surg. Oncol., February 1, 2007; 14(2): 670 - 677. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Soran, T. Evrensel, G. Ahrendt, B. Kocer, and R. Johnson Use of the Breast Cancer Nomogram to Predict Non-Sentinel Nodal Positivity in Patients Having Received Pre-Operative Chemotherapy Ann. Surg. Oncol., January 1, 2007; 14(1): 165 - 165. [Full Text] [PDF] |
||||
![]() |
N. Jonjic, E. Mustac, A. Dekanic, B. Marijic, B. Gaspar, I. Kolic, M. Coklo, and F. Sasso Predicting Sentinel Lymph Node Metastases in Infiltrating Breast Carcinoma With Vascular Invasion International Journal of Surgical Pathology, October 1, 2006; 14(4): 306 - 311. [Abstract] [PDF] |
||||
![]() |
A. L. Allan, R. George, S. A. Vantyghem, M. W. Lee, N. C. Hodgson, C. J. Engel, R. L. Holliday, D. P. Girvan, L. A. Scott, C. O. Postenka, et al. Role of the Integrin-Binding Protein Osteopontin in Lymphatic Metastasis of Breast Cancer Am. J. Pathol., July 1, 2006; 169(1): 233 - 246. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Houvenaeghel, C. Nos, H. Mignotte, J. M. Classe, S. Giard, P. Rouanet, F. P. Lorca, J. Jacquemier, and V. J. Bardou Micrometastases in Sentinel Lymph Node in a Multicentric Study: Predictive Factors of Nonsentinel Lymph Node Involvement--Groupe Des Chirurgiens De La Federation Des Centres De Lutte Contre Le Cancer J. Clin. Oncol., April 20, 2006; 24(12): 1814 - 1822. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. D. Bear Sentinel Node Micrometastases and Non-Sentinel Nodes in Breast Cancer: How Much Do We Need to Know? J. Clin. Oncol., April 20, 2006; 24(12): 1788 - 1790. [Full Text] [PDF] |
||||
![]() |
H. C. Snider Jr., E. Rubin, and R. Henson Axillary Ultrasonography to Detect Recurrence After Sentinel Node Biopsy in Breast Cancer Ann. Surg. Oncol., April 1, 2006; 13(4): 501 - 507. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Mabry and A. E. Giuliano The Practical Value of Prediction: A Semireliable Assistant Ann. Surg. Oncol., March 1, 2006; 13(3): 282 - 284. [Full Text] [PDF] |
||||
![]() |
L. A. Lambert, G. D. Ayers, R. F. Hwang, K. K. Hunt, M. I. Ross, H. M. Kuerer, S. E. Singletary, G. V. Babiera, F. C. Ames, B. Feig, et al. Validation of a Breast Cancer Nomogram for Predicting Nonsentinel Lymph Node Metastases After a Positive Sentinel Node Biopsy Ann. Surg. Oncol., March 1, 2006; 13(3): 310 - 320. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. B. Chagpar Predicting Extensive Nodal Disease in Women With Breast Cancer Ann. Surg. Oncol., January 1, 2006; 13(1): 3 - 4. [Full Text] [PDF] |
||||
![]() |
A. K. Rivers, K. A. Griffith, K. K. Hunt, A. C. Degnim, M. S. Sabel, K. M. Diehl, V. M. Cimmino, A. E. Chang, P. C. Lucas, and L. A. Newman Clinicopathologic Features Associated With Having Four or More Metastatic Axillary Nodes in Breast Cancer Patients With a Positive Sentinel Lymph Node Ann. Surg. Oncol., January 1, 2006; 13(1): 36 - 44. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Smidt, D. M. Kuster, G. J. van der Wilt, F. B. Thunnissen, K. J. Van Zee, and L. J. A. Strobbe Can the Memorial Sloan-Kettering Cancer Center Nomogram Predict the Likelihood of Nonsentinel Lymph Node Metastases in Breast Cancer Patients in The Netherlands? Ann. Surg. Oncol., December 1, 2005; 12(12): 1066 - 1072. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. E. Davidson, M. Morrow, D. B. Kopans, and F. C. Koerner Case 35-2005 -- A 56-Year-Old Woman with Breast Cancer and Isolated Tumor Cells in a Sentinel Lymph Node N. Engl. J. Med., November 17, 2005; 353(20): 2177 - 2185. [Full Text] [PDF] |
||||
![]() |
G. H. Lyman, A. E. Giuliano, M. R. Somerfield, A. B. Benson III, D. C. Bodurka, H. J. Burstein, A. J. Cochran, H. S. Cody III, S. B. Edge, S. Galper, et al. American Society of Clinical Oncology Guideline Recommendations for Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer J. Clin. Oncol., October 20, 2005; 23(30): 7703 - 7720. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Specht, M. W. Kattan, M. Gonen, J. Fey, and K. J. Van Zee Predicting Nonsentinel Node Status After Positive Sentinel Lymph Biopsy for Breast Cancer: Clinicians Versus Nomogram Ann. Surg. Oncol., August 1, 2005; 12(8): 654 - 659. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. M. Kuerer and L. A. Newman Lymphatic Mapping and Sentinel Lymph Node Biopsy for Breast Cancer: Developments and Resolving Controversies J. Clin. Oncol., March 10, 2005; 23(8): 1698 - 1705. [Full Text] [PDF] |
||||
![]() |
D. R. McCready RESPONSE: Re: Influence of the New AJCC Breast Cancer Staging System on Sentinel Lymph Node Positivity and False-Negative Rates J Natl Cancer Inst, November 3, 2004; 96(21): 1639 - 1640. [Full Text] [PDF] |
||||
![]() |
K. M. McMasters The Eternally Enigmatic Axilla: Further Controversy About Axillary Lymph Nodes in Breast Cancer Ann. Surg. Oncol., December 1, 2003; 10(10): 1128 - 1130. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |